| 发明名称 |
Modulation of Beta 2 Adrenergic Receptors by Inhibitors of EGLN3 or pVHL |
| 摘要 |
This present invention relates to methods, compositions, and kits useful for treating a patient having or at risk for developing a disorder associated with decreased expression of &bgr;2 adrenergic receptors or need for increased 132 adrenergic receptor activity. |
| 申请公布号 |
US2012121720(A1) |
申请公布日期 |
2012.05.17 |
| 申请号 |
US201013256954 |
申请日期 |
2010.03.31 |
| 申请人 |
STAMLER JONATHAN S.;XIE LIANG |
发明人 |
STAMLER JONATHAN S.;XIE LIANG |
| 分类号 |
A61K31/225;A61K31/403;A61K31/713;A61K33/00;A61K35/14;A61K35/28;A61K38/06;A61K38/10;A61P3/00;A61P7/06;A61P7/10;A61P9/00;A61P9/04;A61P9/06;A61P9/10;A61P9/12;A61P11/00;A61P11/06;A61P25/06;A61P25/08;A61P25/22;A61P27/06;A61P39/04 |
主分类号 |
A61K31/225 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
